Big Gain For Galmed Pharmaceuticals Ltd.
Mon, Dec 02, 2019 at 05:30 PM
Galmed Pharmaceuticals Ltd. (GLMD:NASDAQ) shot up at $5.82, representing a gain of 29.3%. On Fri 29 Nov 19, GLMD:NASDAQ hit a New 2-Week Intraday High of $4.59. The stock got featured on our News Catalysts scanner on Wed 06 Nov 19 at 08:21 AM in the 'INVESTOR UPDATE' category. From Fri 08 Nov 19, the stock recorded 50.00% Up Days and 40.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Galmed Pharmaceuticals Ltd. (GLMD:NASDAQ)
Galmed Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of oral therapy for the treatment of liver diseases and cholesterol gallstones.
Top 10 Gainers:
- Kodiak Sciences Inc. (KOD:NASDAQ), 72.47%
- Onconova Therapeutics, Inc. (ONTX:NASDAQ), 56.33%
- Sierra Oncology, Inc. (SRRA:NASDAQ), 44.22%
- Yield10 Bioscience, Inc. (YTEN:NASDAQ), 41.09%
- ASLAN Pharmaceuticals Limited (ASLN:NASDAQ), 36.13%
- Oramed Pharmaceuticals Inc. (ORMP:NASDAQ), 29.71%
- Galmed Pharmaceuticals Ltd. (GLMD:NASDAQ), 29.33%
- NF Energy Saving Corporation (BIMI:NASDAQ), 28.9%
- SAExploration Holdings, Inc. (SAEX:NASDAQ), 28.57%
- Hexindai Inc. (HX:NASDAQ), 26.88%